The effects of metformin on clinical features, endocrine and metabolic profiles of infertile women with polycystic ovary syndrome

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. Insulin resistance appears to be a critical factor in PCOS pathogenesis. Metformin, an insulin-sensitizing agent, is thus the preferred treatment option for PCOS.